BBK Capital Partners »

Cytomx Therapeutics shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $475k 306k 1.55
2023-09-30 $410k 318k 1.29
2023-06-30 $547k 318k 1.72
2023-03-31 $480k 318k 1.51
2022-12-31 $509k 318k 1.60
2022-09-30 $451k 311k 1.45
2022-06-30 $380k 208k 1.83